Metraipolis › archive › dc_989f68d17399

Analgesia through FKBP51 inhibition at disease onset confers lasting relief from sensory and emotional chronic pain symptoms — Europe PMC PMID:41166420

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41166420
DOI
10.1073/pnas.2517405122
License (as archived)
solo-consultazione
Archived
2026-11-08T22:56:27.022Z
SHA-256 of the archived text
a46364be7bfd07133f941899d169eea27baefc139ea4c9c700a07b426b930f4c
Stable URL of this page
https://metraipolis.com/documento/dc_989f68d17399

How to cite

Analgesia through FKBP51 inhibition at disease onset confers lasting relief from sensory and emotional chronic pain symptoms — Europe PMC PMID:41166420 — Europe PMC (en), https://europepmc.org/article/MED/41166420 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_989f68d17399 (Metraipolis archive dc_989f68d17399, sha256 a46364be7bfd07133f941899d169eea27baefc139ea4c9c700a07b426b930f4c)
BibTeX
@misc{dc989f68d17399,
  title = {Analgesia through FKBP51 inhibition at disease onset confers lasting relief from sensory and emotional chronic pain symptoms — Europe PMC PMID:41166420},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41166420},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_989f68d17399; sha256 a46364be7bfd07133f941899d169eea27baefc139ea4c9c700a07b426b930f4c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41166420. Agents can read the archived copy with the MCP tool read_document.